Autoantibodies that target various molecules including post‐translationally modified self‐epitopes (e.g., rheumatoid factor [RF] and anticitrullinated protein/peptide antibodies [ACPA]) have been found in two thirds of RA patients and can be detected years before the onset of the disease [8]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.